Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fenoprofen is a nonsteroidal anti-inflammatory drug (NSAID) of the propionic acid class used to treat mild to moderate pain and symptoms of arthritis, including osteoarthritis and rheumatoid arthritis. It works primarily by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), leading to decreased synthesis of prostaglandins that mediate inflammation, pain, and fever. Fenoprofen is available as oral capsules or tablets under several brand names. Its analgesic and anti-inflammatory effects are comparable to aspirin but with a potentially lower incidence of certain gastrointestinal side effects. The drug does not cure arthritis but provides symptomatic relief as long as it is taken[1][2][3][4][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fenoprofen.